Biosimilars 2016 Report
Conference Series LLC hosted the 6th International Conference and Exhibition on Biologics and Biosimilars at Crowne Plaza Houston River Oaks in Houston, TX, USA during October 19-21, 2016. The conference was designed around the theme of “The Present Scenario and Future Prospects of Biologics and Biosimilars” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.
Biosimilars 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a biosimilar.
Conference Series LLC would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Biosimilars 2016.
Laszlo Endrenyi, University of Toronto, Canada
Oxana Iliach, Quintiles Inc., Canada
Mario DiPaola, Blue Stream Laboratories, Inc., USA
Kristin Connarn, McDermott Will & Emery, USA
Marlene LLopiz Aviles, Association of Medical Specialists in Pharmaceutical Industry, Mexico
We on behalf of the conference specially thank the exhibitors for their participation in the congress and also the media partners for their wonderful marketing of the event. Conference Series LLC also took the privilege of felicitating Biosimilars 2016 Organizing Committee, Keynote Speakers, Chair and Co-Chairs whose support made conference a great success.